Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. IL99864 - COMPOSITIONS FOR SUPPRESSING TRANSPLANT REJECTION IN MAMMALS WHICH CONTAIN TISSUE DONOR DERIVED MHC ANTIGENS

Office Israël
Numéro de la demande 99864
Date de la demande 27.10.1991
Numéro de publication 99864
Date de publication 21.11.2000
Type de publication B
CPC
A61K 35/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
26Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
A61K 35/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61K 39/001
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
0005Vertebrate antigens
001Preparations to induce tolerance to non-self, e.g. prior to transplantation
A61P 37/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
06Immunosuppressants, e.g. drugs for graft rejection
A61P 41/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
41Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Déposants AUTOIMMUNE, INC.
Mandataires סנפורד ט. קולב ושות'
Données relatives à la priorité 607826 31.10.1990 US
Titre
(EN) COMPOSITIONS FOR SUPPRESSING TRANSPLANT REJECTION IN MAMMALS WHICH CONTAIN TISSUE DONOR DERIVED MHC ANTIGENS
(HE) תכשירים לדיכוי דחיית השתלות ביונקים שמכילים אנטיגנים ה- MHC הנגזרים מתורם הרקמה
Abrégé
(EN)
A pharmaceutical formulation for suppression of transplant rejection by oral or enteral or aerosol administration to a recipient mammal about to undergo or having undergone transplant surgery from a donor mammal, the pharmaceutical formulation comprising an agent selected from the group consisting of splenic tissue from said donor, lysates of said splenic tissue containing MHC antigens, cultured lymphocytes from said donor, lysates of said cultured lymphocytes containing MHC antigens, MHC antigens from said donor, fragments of said MHC antigens and analogs of said MHC antigens.

Également publié en tant que
NO19931536